1 Screening van Zwangeren op Groep B Streptokokken. W.B.A. Mei 2003 L. Mahieu, Dienst Neonatologie,...

Screening van Zwangeren op Groep B Streptokokken.

W.B.A. Mei 2003

L. Mahieu, Dienst Neonatologie, U. Z. AntwerpenL. Mahieu, Dienst Neonatologie, U. Z. Antwerpen

Inhoud

• Epidemiologie

• Microbiologie

• Kliniek

• Pathogenese

• Preventie mogelijkheden

• Toestand in Vlaanderen

• Richtlijnen

The Disease - USA• GBS emerged as an important pathogen in the

• Leading cause of sepsis in neonates

• Incidence: 0.4-4/1000. (Belgium= 2/1000)

• Motality > 14%

• Belgium: – 240 cases/year– 48 deads/ year

Comparison with other Killers in Childhood.

• Meningococcal Invasive Disease– Incidence 2.3/100.000 children– Dead 0.2/100.000 children

• Road Accidents– Incidence 2.5 deads/ 100.000 children

• GBS invasive disease– Incidence 220/ 100.000 newborns– Deads 33/100.000 newborns

Neonatal GBS is an underestimated Public Health Problem.

Invasive GBS Disease Incidence by Age Group and

Age group

Whites Blacks

MMWR Vol. 41 (No. SS-6) 1992

GBS Disease in Infants

0102030405060708090

1 2 3 4 5 6 7 8 9 10 11

Age (months)

A Schuchat. Clin Micro Rev 1998;11:497-513.

Early-Onset Neonatal GBS Disease

0102030405060708090

0 1 2 3 4 5 6

Age (days)

A Schuchat. Clin Micro Rev 1998;11:497-513.

Clinical Manifestations of Group B Streptococcus Infection

Early-Onset Infection• < 6 days of life

• 85% :within 24 hours of birth

• case:fatality ratio 5-10%

low 5 min Apgar, shock, neutropenia, pleural effusion, apnea, delay treatment, low birth weight, prematurity

• 25-40%

• respiratory signs = initial clinical findings

(apnea, grunting respirations, tachypnea, cyanosis)

• hypotension

• associated signs: – lethargy, poor feeding, hypothermia or fever,

abdominal distention, pallor, tachycardia, jaundice

Early-Onset Infectionbacteremia without focus

• 5-10%, especially serotype III strains

• clinical presentation ~ bacteremia

• most common sign = Convulsions

THUS: CSF !!

• persistent seizures, (semi)coma

= poor prognosis

Early-Onset Infectionmeningitis

• 35 - 55%• acute respiratory signs: grunting, tachypnea, apnea• often at birth, most < 24h• low Apgar (<5 at 1min)• X-ray abnormalities:

– > 50% HMD– 30% infiltrates– occasionally absent (~ persistent fetal circulation)

Early-Onset Infectionpneumonia

• Profound progressive hypoxemia that is usually out of proportion to the radiographic evidence of pulmonary disease

Early-Onset Infectionpersistent fetal circulation

Early-Onset Infectionpneumonia

• 7 days - 12 weeks postnatal age

• case:fatality ratio 2-6%

• serotype III strains

• “clusters” in NICU (~ early onset)

• manifestations:– meningitis– bacteremia without focus– focal: osteomyelitis, septic arthritis, cellulitis, adenitis

Late-Onset Infection

Late-Onset Infectionosteomyelitis / septic arthritis

• low incidence, high morbidity disease

• EOS = Pneumonia PFC hypoxia death

• LOS = Meningitis

GBS DiseaseBig Disease with a Little Name

Maternal to Infant TransmissionGBS colonized mother

Non-colonized newborn

Colonized newborn

Asymptomatic Early-onset sepsis, pneumonia, meningitis

50% 50%

98% 2%

Risk Factors

• GBS strain virulence• Genital inoculum• GBS bacteriuria• Delivery <37 weeks’ gestation• Premature rupture of membranes• Rupture of membranes >18 hours• Low levels of CPS-specific IgG• Complement component deficiency• Immature WBC function

Early-Onset Infectionrisk factors

GBS Maternal Colonization

• GBS Carriers– 10% - 30% of women (Belgium= 13-25%)– higher in African Americans and nonsmokers– clinical signs not predictive (Asymptomatic)– dynamic condition

• When to culture?– culture at delivery -- too late– prenatal cultures predict delivery status

Prevention with Antibiotics

• WHEN are antibiotics most effective?– Antenatal– Postnatal– Intrapartum

• WHO should receive antibiotics ?– GBS carriers– OB risk factors– GBS carriers with OB risk factors

Consensus Guidelines

• Key Issues– predictive value of prenatal cultures– culture methods– disease in the asymptomatic carrier– risk stratification of women– cost-effectiveness

GBS Screening

WHEN ?

Predictive Value of Antenatal Cultures by Interval to

Delivery

6 5 4 3 2 1

Weeks before delivery

PPV NPV

N=826; 26.5% GBS carriersYancey et al., OB GYN 1996;88:811-5.

Sensitivity and Specificity of Late Antenatal Cultures

898597

Weeks before delivery

sensitivity specificity

N=826Yancey et al., OB GYN 1996;88:811-5.

GBS screening

WHERE ?

GBS Carriage by Culture Site

Women instudy (#)

Vagina (%) Anorectum (%) Both (%)

789 10 18 21*

94 18 28 31*

301 11 14 18*

* P <0.05 both vs. vaginal only

Specimen technique

• Lower vagina + Rectum (through anal sphincter)– One swab

– Without speculum

– Out patient setting or patient herself

• Transport– non-nutritive medium (Amies, Stuart’s without

charcoal)

– Store at room t° or in fridge (max. 48h)

GBS culture

GBS Carriage by Culture Method

Women instudy (#)

Selectivebroth (%)

Blood agarplate (%)

166 34 14*

952 17 9*

383 20 13*

* P <0.05 selective broth vs. blood agar

What is ‘Selective Broth Medium’?

• 1. Incubatie overnight on 35-37°C:– Todd-Hewitt broth supplemented with:

• nalidixic acid (15 mg/L) and colistin (10 mg/L)

– Appropriate media are commercially available (e.g. LIM broth [BD])

• 2. Subculture 18-24h:– Granada medium agar (Biomedics, Spain or

distr. by International Medical)• (anaerobically or glass coverslip)

Granada mediumOrange colonies

Is Intrapartum Screening an Alternative?

Intrapartum screening

• Sensitivity should be > 85% (= culture)

• Rapid

• Covenient for laboratory– 24h a day– 7 days a week

• Alternatives

Intrapartum GBS Screening- Intrapartum GBS Screening- AlternativesAlternatives

• GBS antigen test.– Sensitivity to low

– Positive= heavy colonization.

– Negative = Unknown colonization.

• Real time PCR.– Sensitivity 97%,

– Specificity 96.9%

– 45 min. Maximum

– Not available on 24h basis

– Not available in every Lab.

At Present No Good Alternative

Communication

• To laboratory;– Clearly request “GBS screening”– Expected site of delivery– Expected time of delivery

• To Clinician; – address of expected delivery (Fax?) – Physician’s office.– Report only QUALITATIVE (Positive or Negative)

GBS screeningGBS screening

CDC’s Prevention Recommendations 1996

PICK EITHER APPROACH:

Screening-based approach

• 35-37 wk culture, offer IAP to preterm and to GBS carriers

Risk-based approach

• IAP to preterm, ROM > 18 h, or intrapartum fever (T > 38 C)

Prevention Strategy Using Risk-Based Approach

Any of the following:• Delivery < 37 wks gestation*• ROM > 18 hrs• Intrapartum temp > 38C (100.4 F)• Previous infant w/GBS disease• GBS bacteriuria this pregnancy

Give intrapartum penicillin

No intrapartum antibiotics

* For ROM w/out labor at <37 wks, collect GBS culture and EITHER:• treat until cultures complete and negative• or begin treatment once positive culture results available

Obstetric Risk Factors Among Women with GBS Infants

* obstetric risk factors

* no obstetric risk factors

n = 245

* premature < 37 wk, ROM > 18 hr, temp > 100.4 F (38 C)

Rosenstein N. OB GYN 1997;90:901-6.

Rates of Early-Onset GBS Disease by Rates of Early-Onset GBS Disease by Prenatal Colonization & Risk FactorsPrenatal Colonization & Risk Factors

5.10.9 0.3

Col+,RF+ Col+,RF- Col-,RF+ Col-,RF-

Col: prenatal vag/rect cultureRF: risk factors (gest. <37 wks, ROM >12 hr, fever > 37.5 C)

Boyer & Gotoff, Antibiot Chemother 1985.

Advantages of the Risk-Based Strategy

• Logistically easier

• Potentially less expensive

• Particularly applicable to settings with low prenatal care

Prevention Strategy Using Screening-Based Approach

Risk factors:• Previous infant w/GBS disease• GBS bacteriuria this pregnancy• Delivery < 37 wks gestation

Collect rectal & vaginal swab at 35-37 wks

No intrapartum prophylaxis needed

Risk factors:• Intrapartum fever > 38C• ROM > 18 hrs

Offer intrapartum penicillin

Not done, incomplete, or results unknown

Advantages of the Screening-Based Strategy

• Optimizes prenatal screening– fewer false negatives– less pressure on physicians to treat

• Antibiotics to all GBS carriers– antibiotics start earlier before development of

risk factors– adequate time for antibiotic effectiveness

Comparison of Prevention Strategies

Prevention Strategy EO GBS casesprevented (%)

Deliveries receivingIAP (%)

Cost compared to nostrategy (%)

Screening-based:35-37 wk screen/IAPfor preterm and GBScarriers

86.0 26.7 43.7

Risk-based:no screen/IAP for allwith risk factors*

68.8 18.3 35.6

* fever, ROM > 12 hr, gestation < 37 wks

Rouse et al., OB GYN 1994;83:483-94.

Potential Impact of Each Strategy

1989 1990 1991 1992 1993 1994 1995 1996

Early-onset GBS disease by Year, Area A

Screening-BasedApproach

Risk-BasedApproach

Rosenstein N, et al., OB GYN 1997;90:901-6.

GBS chemoprophylaxis

WHEN to Start ?

Timing of Intrapartum Ampicillin and Transmission of

GBSInterval between

ampicillin and birthNo. of GBS carrier

mothersNo. (%) GBS

colonized babiesControls

(no ampicillin)209 98 (47)

< 1 hour 30 13 (43)

1-2 hours 36 7 (19)

2-4 hours 80 2 (2.4)

>4 hours 105 1 (0.9)

De Cueto et al., OB GYN 1998;91:112-4.

GBS chemoprophylaxis

What to Start ?

Antimicrobial Resistance in Antimicrobial Resistance in Belgium.Belgium.

-lactams (Pen, Amp, Cephalo-I) : – Today 100 % Sensitive!

Erythromycine & Clindamycine– Belgium : 10 à 20 % in 2001– 88 % type MLS (20 % inducable)

P. Melin (ULG)

Intrapartum Prophylaxis

• Penicillin G– 5 million units IV load, then 2.5 million units

IV every 4h until delivery

• Ampicillin– 2 g IV load, then 1g IV every 4h until delivery – acceptable alternative, but broader spectrum

may select for resistant organisms

• Penicillin “allergic”– History = 12%

– Proven peni-allergy is only 1-2%

• Alternative drugs:– No anaphylaxic history: cephalosporins 1st. Gen.

(cephazolin)• Loading: 2g, then 1g IV Q8h

– Clindamycin (Dalacin)• 900 mg Q8h

– Vancomycin (Vancocin) in Clinda-R organisms?

Intrapartum Prophylaxis

Efficacy of these drugs NOT proven !

Impact of

Prevention?

Incidence of GBS Disease and Hospital Prevention Policy

0.90.8

0.70.6

0.20.4

1.61.8

TN GA MN OR MD CA CT

Rate of Early-OnsetGroup B Streptococcal Disease

By Surveillance Site in 1996

Percent of Hospitals with aGroup B Streptococcal

Prevention Policy in 1996

Early-Onset GBS Disease by Year and Location

Active Surveillance (190,000 births/year)

SF MD Atlanta TN Total

1993 1994 1995 1996 1997

MMWR 1997;46 (No. 21):473-77.

What we Think

is NOT

What we Do !

Flemish Obstetricians’ profile Flemish Obstetricians’ profile in 1999in 1999

- A Survey.- A Survey.

L.MahieuL.Mahieu et al, 2000, J Obst Gyn;5:460-4 et al, 2000, J Obst Gyn;5:460-4

Survey - ObjectiveSurvey - Objective

– Flemish obstetricians’ attitude regarding the prevention of perinatal GBS.

– To determine the physician characteristics that predict divergent opinions from the screening based approach

• Mailing list (VVOG)• Anonymous survey:

– 4 pages– 5 min.– Dichotomized questions (yes/no)– Items: screening, prophylaxis, demografic

• Send ones• Pre-stamped envelope

Survey - MethodsSurvey - Methods

ResultsResultsDemografic CharacteristicsDemografic Characteristics

• Surveys returned by 310 (53%) of 582

• Age: 40 (25-79) years

• Gender: 62% male

• No. of deliveries: 153 (10-500) / year

• Hospital: 18% university, 64% non-academic, 18% rural

• Obstetrical interests: 61%

• Group practice: 56%

• Never (4.2%):– No consensus– Does not influence AB prophylaxis

• Always (44%):– Indication for AB therapy– Negative experience– Routine

• If “risk factor” (52%):– PPROM– previous child GBS+

ResultsResultsScreening - Screening - Who?Who?

ResultsResultsScreening - Screening - Where?Where?

Cervix Vagina Vagina +Rectum

Cervix +Introitusvaginae

ResultsResultsScreening - Screening - When?When?

26-28w 28-34w 35-37w intralabour

ResultsResultsProphylaxis - Prophylaxis - When?When?

OnsetLabour

BeforeLabour

BeforePartus

OnsetPartus

AfterPartus

ResultsResultsProphylaxis - Prophylaxis - What?What?

0,3 1,3

Ampicillin Amoxi-Clav Penicillin Clindamycin Other AB

9.648.227.63 9.09

Independent Demographic Predictors of Independent Demographic Predictors of Compliance to CDC Guidelines (*)Compliance to CDC Guidelines (*)

2 3 4 5 6 7

Leeftijd van de verloskundige (decaden)

reIndependent Demographic Predictors of Independent Demographic Predictors of

Compliance to CDC Guidelines (*)Compliance to CDC Guidelines (*)

• Minority (44%) believe in routine prenatal GBS screening.

• 1/3 screen at cervix.

• 3/4 use broadspectrum AB (ampi, +/- clavulanic acid).

• Compliance to guidelines is influenced by:– province (E- & W-Flanders)– High age of Obstetrician

ConclusionsConclusionsPriorities for Improvement?Priorities for Improvement?

Managment of the Neonate at Risk for GBS.

The Symptomatic Neonate• Full diagnostic evaluation

– FBC + differential– CRP– Culture blood– Culture CSF (if indicated)– Endotracheal cultures (ventilated infant)– Surface cultures (nose and/or ear)

• Start antibiotics: Ampicillin + AG.– 10 days for sepsis, 14 days for meningitis, 28 days for ventriculitis,

osteomyletis– AG stop after 3-5 days.

Asymptomatic Newborn at Risk.

• Limited evaluation if– Duration of IAP < 4h (< 2 doses)– Optimal IAP but Gestation < 35 weeks

• Serial measurement at birth, 12h and/or 24h – FBC– CRP– No cultures unless AB treatment is started.

Laboratory Indices for EOS.

LimitsNeutrophil

0H 6H 12H 18H 24H

LOW 1800 5400 8000 8000 7200

HIGH 7000 13000 14400 13000 12500

CRP > 1.4 mg/dL or Increase (X 2-4).

Leucopenia < 5000/mm³

Sample Algorithm for Management of Newborn if Maternal IAP

Maternal IAP for GBS?

• Full diagnostics evaluation• Empiric therapy

yesSigns/sx of sepsis in newborn?

Gestational age

Duration of maternal IAP before delivery

• No evaluation• No therapy• Observe at least 48 hrs

35 wks+

>4 hrs or >2 doses

< 4 hrs or< 2 doses

• Limited evaluation• Observe at least 48 hrs• If sepsis suspected, full diagnostic evaluation and empiric therapy

< 35 wks

Adjuvant Treatment

• IV Immunoglobulines?– opsonisation

• Cytokines?– GM-CSF– G-CSF

• Surfactant?– SP-A

• NO

Hoge Gezondheidsraad-2003Ministerie van Volksgezondheid en

Leefmilieu

Microbilogist:• Mellin P.• Claeys G.• Naessens A.•Hubinon C.

Gynecologists:• De Mol P.• Donders G.• Temmerman M.• Beckstedde I.• Foulon W.•Van Eldere J.

Pediatricians:• Mahieu L.• Tuerlinckx D• Levy J• Lepage P.

Ministery: DeVleeschouwer G./ Dubois J.

Need for Continuous Medical

Education

development ofWritten Guidelines

L. Mahieu et al. Obstet. Gynecol. 2000; 20: 460-464

Evaluating Prevention Programs

• Consider developing surveillance for:– Neonatal GBS disease?– Adverse reactions to prophylaxis?– Emergence of resistant perinatal infections?

• Economic evaluation?

• Compliance to guidelines?

Perinatale GBS.

Beter voorkomen.

Dan genezen !

1 Screening van Zwangeren op Groep B Streptokokken. W.B.A. Mei 2003 L. Mahieu, Dienst Neonatologie,...

Documents

Transcript of 1 Screening van Zwangeren op Groep B Streptokokken. W.B.A. Mei 2003 L. Mahieu, Dienst Neonatologie,...

Dienst Distributed Networked Publishing

© fedict 2005. All rights reserved User satisfaction & impact measurement Belgian practice Description using the Template Christine Mahieu, Business Analyst.

GHID PEDIATRIE-NEONATOLOGIE

EL&I: Dienst regelingen

Boekpresentatie Tot uw dienst

dekalb.illinoisgenweb.org · Dr. Thomas F. Elizabeth Disbrow Elizabeth Mc Nary Elizabeth. Baker, John Bannister, Clyde ... Mabel le Ann Gerhardt Dienst, Magdalena Dienst, Mary A.

Dienst A. & C. · Subject: Image Created Date: 1/29/2010 9:50:02 AM

Globalization of education policy Lennart Spolander, Director of Studies Ron Mahieu, Senior Lecturer.

La geografia secreta de america jacques de mahieu

PROJECT - mahieu-cs.bemahieu-cs.be/downloads/glasvezelbekabeling-is-onze-specialiteit.pdf · In ‘94 kwam Wim Mahieu aan het hoofd van het installatiebedrijf. De Waregemse onderneming,

Arbeitsvorlage für ISTL - David Dienst

GENTAMICINE ET VANCOMYCINE EN NEONATOLOGIE ET … · TDM GENTAMICINE ET VANCOMYCINE EN NEONATOLOGIE ET EN PEDIATRIE ... Anémie physiologique nourrisson à terme (après 8 à 12 sem

FAQ Pinnen over IP-dienst van SURFnet

Psychologie in der Neonatologie - Amazon Web Services · 2017-11-14 · Berlin. 2000 Facharztprüfung und 2005 Erwerb der Schwerpunktbezeichnung Neonatologie. 2005 Habilitation. 2004

La geografia secreta de america jacques de mahieu

Buckets, Clusters and Dienst - NASA€¦ · Buckets, Clusters and Dienst Michael L. Nelson ' Langley Research Center, Harry.ton, Virginia ... We show that the overhead for these additional

Dienst Elektronische en Mechanische Ontwikkeling

Dienst Distributed Networked Publishing Carl Lagoze Digital Library Scientist Cornell University.

Das Webportal Map UpDate UnD Der Map Care-Dienst

Résumé Key-words contr le - UCLouvainperso.uclouvain.be/vincent.yzerbyt/Mahieu et al. RIPS 2014.pdf · E-mails: timothee.mahieu@uclouvain.be; olivier.corneille@uclouvain.be; vincent.